-
1. Tofacitinib as Induction and Maintenance Therapy for Ulcerativ…
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa1606910
Description: WEBMay 4, 2017 · Tofacitinib inhibits all JAKs but preferentially inhibits JAK1 and JAK3, 10,11 and it was shown to have dose-dependent efficacy as induction …
-
2. Tofacitinib in the treatment of ulcerative colitis: efficacy and saf…
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535722/
Description: WEBMay 16, 2019 · Oral formulation of tofacitinib has recently been approved for the treatment of patients with moderate–severe ulcerative colitis. Its …
-
3. Review article: guide to tofacitinib dosing in patients with ulcerative
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544682/
Description: WEBAug 22, 2022 · Background. Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). The induction dose is 10 …
-
4. Tofacitinib as Induction and Maintenance Therapy for Ulcerativ…
Link: https://pubmed.ncbi.nlm.nih.gov/28467869/
Description: WEBMay 4, 2017 · Background: Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for …
-
5. Real-world experience with tofacitinib in ulcerative colitis: a
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721385/
Description: WEBDec 23, 2021 · Tofacitinib is a Janus kinase inhibitor (JAKi) recently approved for the treatment of moderate to severe ulcerative colitis (UC) based on robust …
